Now I have enough information to produce the consolidated review. Let me write it.

## Summary

This paper proposes SCREENER, a fully self-supervised framework for unsupervised anomaly segmentation in 3D CT images. It comprises three components: (1) a self-supervised descriptor model that produces dense feature maps invariant to local augmentations, (2) a self-supervised condition model trained to be invariant to image masking (thereby ignoring local anomalies while capturing global context), and (3) a conditional density model (Gaussian or normalizing flow) that estimates the conditional density of descriptors given their context. The method is trained on 30,000+ unlabeled 3D CT volumes and evaluated on 1,820 test scans across four pathologies (lung cancer, pneumonia, liver tumors, kidney tumors), substantially outperforming prior unsupervised methods including reconstruction-based, synthetic-anomaly, and ImageNet-feature-based approaches.

## Strengths

- **Self-supervised 3D descriptors substantially outperform ImageNet features for medical UVAS.** Table 4 shows that the SSL-pretrained VICReg descriptor (d=32) with a flow density model achieves 79.4 AUPRO on LIDC vs. 68.8 for MSFlow (which uses ImageNet-pretrained features). The margins are large enough (~10+ points) to robustly support the claim that domain-specific SSL representations are more effective for 3D medical CT.

- **Masking-invariant condition model enables simple density models to approach flow-based performance.** Table 3 demonstrates that with the learned condition model, a Gaussian density model achieves 86.0 AUROC on LIDC vs. 81.2 with sin-cos positional encoding and 70.7 without conditioning — closing much of the gap to the normalizing flow (87.2 AUROC). This is a clear and well-supported contribution.

- **First large-scale UVAS evaluation on 3D CT across multiple pathologies.** The paper trains on 30,000+ volumes from three CT datasets and evaluates on 1,820 scans from four distinct pathology datasets spanning chest and abdomen. This provides the first comprehensive benchmark for unsupervised anomaly segmentation in 3D medical imaging (as claimed in the contributions).

- **Comprehensive ablation study with modular design.** Sections 4.4–4.5 systematically ablate the descriptor model (contrastive vs. VICReg, varying dimension), condition model (none, sin-cos, anatomical, self-supervised), and density model (Gaussian vs. normalizing flow). This thoroughness strengthens the validity of the conclusions.

- **Practical advantage: no requirement for anomaly-free training data.** The method trains on real-world CT datasets that naturally contain unlabeled pathologies, overcoming a key limitation of reconstruction-based and synthetic-anomaly methods. This is well-argued and empirically demonstrated.

## Weaknesses

### Fatal
None.

### Major
None.

### Minor

- **No statistical uncertainty reported.** The paper reports point estimates for all metrics (Tables 2–4) without standard deviations, confidence intervals, or any measure of variance. While the main results (Table 2) show large margins (~15–30 points) where this is less concerning, the ablation studies (Tables 3, 4) contain comparisons where differences are small (e.g., ~0.8 AUROC between conditioning strategies with flow density). Without error bars, the reader cannot assess whether these smaller differences are meaningful or within the noise. This does not threaten the core contribution (which relies on the large-margin main results), but it limits confidence in the finer-grained ablation conclusions.

- **Confounded comparison between SSL descriptors and ImageNet features.** Table 4's comparison pits SCREENER's 3D SSL encoder against MSFlow, which uses an ImageNet-pretrained 2D ResNet encoder. The architecture (3D fully-convolutional vs. 2D ResNet), dimensionality, and pre-training domain all differ simultaneously. As presented, this experiment demonstrates that "a domain-specific 3D SSL model outperforms a general-domain 2D supervised model"—informative but weaker than the clean claim that "SSL beats supervised features for medical CT." The large magnitude of the gap (~10+ AUPRO points) makes it unlikely the ranking would reverse, but the confound should be acknowledged more explicitly.

- **No per-dataset breakdown of results.** The four test datasets (LIDC, MIDRC-RICORD-1a, KiTS, LiTS) cover different pathologies and anatomical regions. Aggregated metrics may obscure where SCREENER excels and where it struggles (e.g., the training data is chest-heavy, potentially affecting abdominal results). A per-dataset breakdown would also partially address the error-bar concern by providing finer-grained evidence.

- **Baseline hyperparameter tuning not specified.** The paper does not state whether baselines were tuned on a validation set or used default settings. Given the large performance gaps, this is unlikely to affect the relative ranking, but stating the tuning protocol explicitly would improve confidence.

### Trivial
None.

## Nice-to-Haves

- **Analysis of failure cases or per-pathology breakdown.** The paper honestly discusses limitations (false positives on rare healthy patterns, anatomical imbalance), but a systematic breakdown of common failure modes would strengthen the contribution. This is a suggestion for extension, not a requirement.

- **Controlled synthetic anomaly experiment.** A synthetic lesion insertion experiment (even on a small subset) could validate that the method's detections correspond to structural deviations rather than statistical outliers. Not standard for this setting but a nice addition.

## Removed Points

These points are flagged to be removed; treat them with caution:

- **"Condition model's benefit is marginal when using flow"** — The paper's own text (line 130) transparently reports that conditioning strategies yield similar results with flow. The paper's contribution is correctly framed as enabling simpler density models (Gaussian) to approach flow performance. This is faithful reporting, not a weakness. Removed because the criticism is an observation the paper already acknowledges and is not a flaw.

- **"No evaluation on generated anomalies or synthetic data (MOOD)"** — The paper explicitly states (line 166) that the MOOD benchmark "is currently closed for submissions." The critic argues this point without checking. Removed as factually incorrect.

- **"Should discuss whether some test sets have more complete annotations than others"** — The paper already discusses annotation incompleteness in Section 4.2 as justification for using AUROC/AUPRO over Dice. Removed as already addressed.

- **Several of the Strength Finder's generic strengths** — e.g., "addressed an important problem" is dropped as it is superficial and nonspecific.

## Novel Insights

The most interesting finding to emerge from reading the paper alongside the reviews is the asymmetric benefit of the condition model: it provides large gains for simple density models (Gaussian: 70.7 → 86.0 AUROC on LIDC with the learned condition) but minimal gains for expressive models (normalizing flow: 86.4 → 87.2). This suggests that the condition model's primary role is providing a strong inductive bias that compensates for limited density estimator capacity, rather than adding genuinely new information that a sufficiently flexible flow cannot already extract from the descriptors themselves. This insight could guide practitioners: if computational budget allows for a normalizing flow, the condition model may be optional; if resources are constrained (Gaussian), it becomes essential.

## Suggestions

1. **Add confidence intervals or bootstrap-derived error bars** to all metric tables, particularly Tables 3 and 4 where pairwise differences are small. Given the 1,820 test scans, bootstrapping is feasible and would significantly strengthen the ablation claims.

2. **Report per-dataset results** (each of LIDC, MIDRC-RICORD-1a, KiTS, LiTS) as a supplementary table or breakdown within the main tables. This would provide finer-grained insight and help identify domain-specific strengths/weaknesses.

3. **Acknowledge the architecture confound in the SSL vs. ImageNet comparison** (Table 4) and, if possible, include a control: compare the SSL-pretrained 3D encoder against a randomly-initialized 3D encoder with the same architecture to isolate the benefit of SSL pre-training from the benefit of 3D features.

4. **Clarify baseline tuning protocol** — state whether each baseline was validated on a held-out set and how hyperparameters were selected.

MY FINAL SCORE: <score>8.0</score>
MY FINAL DECISION: <decision>Accept</decision>